The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes
- 9 October 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 211 (11) , 1630-1642
Abstract
Peptide loading of MHC class II (MHCII) molecules is facilitated by HLA-DM (DM), which catalyzes CLIP release, stabilizes empty MHCII, and edits the MHCII-bound peptide repertoire. HLA-DO (DO) binds to DM and modulates its activity, resulting in an altered set of peptides presented at the cell surface. MHCII–peptide presentation in individuals with type 1 diabetes (T1D) is abnormal, leading to a breakdown in tolerance; however, no direct measurement of the MHCII pathway activity in T1D patients has been performed. In this study, we measured MHCII Ag-processing pathway activity in humans by determining MHCII, MHCII–CLIP, DM, and DO levels by flow cytometry for peripheral blood B cells, dendritic cells, and monocytes from 99 T1D patients and 97 controls. Results showed that MHCII levels were similar for all three APC subsets. In contrast, MHCII–CLIP levels, independent of sex, age at blood draw, disease duration, and diagnosis age, were significantly increased for all three APCs, with B cells showing the largest increase (3.4-fold). DM and DO levels, which usually directly correlate with MHCII–CLIP levels, were unexpectedly identical in T1D patients and controls. Gene expression profiling on PBMC RNA showed that DMB mRNA was significantly elevated in T1D patients with residual C-peptide. This resulted in higher levels of DM protein in B cells and dendritic cells. DO levels were also increased, suggesting that the MHCII pathway maybe differentially regulated in individuals with residual C-peptide. Collectively, these studies show a dysregulation of the MHCII Ag-processing pathway in patients with T1D.Keywords
Funding Information
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (AI 115452)
- Robert Wood Johnson Foundation (67038)
- Barile Children’s Medical Research Trust (N/A)
- Janssen Research and Development, LLC (N/A)
This publication has 102 references indexed in Scilit:
- Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machineryImmunity, 2021
- Toward understanding the origin and evolution of cellular organismsProtein Science, 2019
- Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-ObImmunity, 2017
- Maintenance of peripheral tolerance to islet antigensJournal of Autoimmunity, 2016
- Type 1 diabetes associated HLA‐DQ2 and DQ8 molecules are relatively resistant to HLA‐DM mediated release of invariant chain‐derived CLIP peptidesEuropean Journal of Immunology, 2015
- Role of B Lymphocytes in the Pathogenesis of Type 1 DiabetesCurrent Diabetes Reports, 2014
- Prevention or acceleration of type 1 diabetes by virusesCellular and Molecular Life Sciences, 2012
- Decreased blood dendritic cell counts in type 1 diabetic childrenClinical Immunology, 2007
- Characteristics at diagnosis of type 1 diabetes in children younger than 6 yearsThe Journal of Pediatrics, 2006
- The Kinetic Stability of MHC Class II:Peptide Complexes Is a Key Parameter that Dictates ImmunodominanceImmunity, 2005